Year archive

Alphamab Oncology — 2025 filings

All 66 regulatory filings released by Alphamab Oncology (9966) in 2025, sourced directly from the official regulator.

66 Filings

2025 Period

2025 filings (66)

Filing	Released	Lang
Next Day Disclosure Return Transaction in Own Shares	2025-12-31	English
VOLUNTARY ANNOUNCEMENT - IND APPLICATION FOR A PHASE II CLINICAL TRIAL OF JSKN033 WAS OFFICIALLY ACCEPTED BY THE CDE Regulatory Filings	2025-12-29	English
VOLUNTARY ANNOUNCEMENT - JSKN003 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION BY THE FDA FOR THE TREATMENT OF PROC Regulatory Filings	2025-12-18	English
VOLUNTARY ANNOUNCEMENT - IND APPLICATION FOR JSKN027 WAS OFFICIALLY ACCEPTED BY THE CDE Regulatory Filings	2025-12-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-04	English
Next Day Disclosure Return Transaction in Own Shares	2025-12-01	English
Next Day Disclosure Return Share Issue/Capital Change	2025-11-27	English
Next Day Disclosure Return Transaction in Own Shares	2025-11-17	English
VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2025-11-07	English
Next Day Disclosure Return Transaction in Own Shares	2025-11-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-06	English
Next Day Disclosure Return Transaction in Own Shares	2025-10-28	English
VOLUNTARY ANNOUNCEMENT - JSKN003 WAS GRANTED FTD BY THE U.S. FDA FOR THE TREATMENT OF PROC Regulatory Filings	2025-10-27	English
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME Transaction in Own Shares	2025-10-24	English
VOLUNTARY ANNOUNCEMENT - JSKN003 WAS GRANTED ANOTHER BREAKTHROUGH THERAPY DESIGNATION BY THE CDE Regulatory Filings	2025-10-20	English
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES OF JSKN003 FOR PRESENTATION AT ESMO CONGRESS 2025 Regulatory Filings	2025-10-20	English
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON A PHASE III CLINICAL TRIAL OF KN026 PRESENTED AT ESMO CONGRESS 2025 LBA ORAL PRESENTATION SESSION Regulatory Filings	2025-10-17	English
Next Day Disclosure Return Transaction in Own Shares	2025-10-16	English
Next Day Disclosure Return Transaction in Own Shares	2025-10-14	English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2024 ANNUAL REPORT Regulatory Filings	2025-10-13	English
Next Day Disclosure Return Transaction in Own Shares	2025-10-13	English
VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2025-10-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-02	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-26	English
ANNOUNCEMENT IN RELATION TO DEALINGS IN SECURITIES OF A DIRECTOR DURING THE BLACK-OUT PERIOD Director's Dealing	2025-09-19	English
VOLUNTARY ANNOUNCEMENT - NDA FOR KN026 (ANBENITAMAB INJECTION) ACCEPTED BY THE NMPA Regulatory Filings	2025-09-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-03	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-28	English
SUPPLEMENT ANNOUNCEMENT CONNECTED TRANSACTION - TECHNOLOGY DEVELOPMENT COLLABORATION WITH SUZHOU ALPHAMAB Regulatory Filings	2025-08-18	English
POSITIVE PROFIT ALERT Earnings Release H1 2025	2025-08-13	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-12	English
CONNECTED TRANSACTION ANNOUNCEMENT - TECHNOLOGY DEVELOPMENT COLLABORATION WITH SUZHOU ALPHAMAB Regulatory Filings	2025-08-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Share Issue/Capital Change	2025-08-05	English
VOLUNTARY ANNOUNCEMENT - IND APPLICATION FOR JSKN022 WAS OFFICIALLY ACCEPTED BY THE CDE Regulatory Filings	2025-08-03	English
VOLUNTARY ANNOUNCEMENT - JSKN003 RECEIVED THE U.S. FDA APPROVAL TO INITIATE A PHASE II CLINICAL STUDY IN THE TREATMENT OF PROC NOT RESTRICTED BY HER2 EXPRESSION Regulatory Filings	2025-07-31	English
VOLUNTARY ANNOUNCEMENT - JSKN003 FOR THE TREATMENT OF GC/GEJ WAS GRANTED ODD BY THE U.S. FDA Regulatory Filings	2025-07-29	English
Next Day Disclosure Return Share Issue/Capital Change	2025-07-17	English
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY DIRECTORS AND SENIOR MANAGEMENT AND EXERCISE OF OPTIONS BY A DIRECTOR Director's Dealing	2025-07-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Share Issue/Capital Change	2025-07-04	English
Terms of Reference of the Nomination Committee Governance Information	2025-06-30	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-06-30	English
(1) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS; AND (2) CHANGE IN COMPOSITION OF THE BOARD COMMITTEES Board/Management Information	2025-06-30	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 12, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-12	English
INSIDE INFORMATION ANNOUNCEMENT - COMPLETION OF PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER Major Shareholding Notification	2025-06-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-04	English
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES OF JSKN003 FOR PRESENTATION AT 2025 ASCO ANNUAL MEETING Regulatory Filings	2025-06-03	English
INSIDE INFORMATION ANNOUNCEMENT - PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER Major Shareholding Notification	2025-06-03	English
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME Director's Dealing	2025-05-29	English
Next Day Disclosure Return Share Issue/Capital Change	2025-05-26	English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 12, 2025 Proxy Solicitation & Information Statement	2025-05-20	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-20	English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES (INCLUDING RESELL OR TRANSFER TREASURY SHARES); (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) Proxy Solicitation & Information Statement	2025-05-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-07	English
VOLUNTARY ANNOUNCEMENT - THE INTERIM ANALYSIS OF A PIVOTAL PHASE II/III CLINICAL TRIAL OF KN026 HAS MET THE PRIMARY ENDPOINT OF PFS Regulatory Filings	2025-04-30	English
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES OF JSKN021 AND JSKN022 FOR PRESENTATION AT 2025 AACR ANNUAL MEETING Regulatory Filings	2025-04-30	English
2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Environmental & Social Information	2025-04-28	English
2024 Annual Report Annual Report FY 2024	2025-04-28	English
(1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME Share Issue/Capital Change	2025-04-23	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Share Issue/Capital Change	2025-04-03	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 Earnings Release FY 2024	2025-03-25	English
VOLUNTARY ANNOUNCEMENT - JSKN003 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION BY THE NMPA Regulatory Filings	2025-03-18	English
DATE OF BOARD MEETING Report Publication Announcement	2025-03-06	English
POSITIVE PROFIT ALERT Earnings Release FY 2024	2025-03-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Share Issue/Capital Change	2025-01-07	English

Filings by year

2026 26 filings
2025 66 filings
2024 57 filings
2023 49 filings
2022 51 filings
2021 48 filings
2020 50 filings
2019 20 filings